• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Regeneron Pharmaceuticals Inc

+ Add to Watchlist

REGN:US

358.920 USD 3.820 1.05%

As of 20:10:00 ET on 09/19/2014.

Company Profile for Regeneron Pharmaceuticals Inc (REGN)

Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The Company has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders.

Contact Information

Regeneron Pharmaceuticals Inc

777 Old Saw Mill River Road
Tarrytown, NY 10591-6707
United States
Phone: 1-914-847-7000
Fax: 1-914-347-2847

Key Executives for Regeneron Pharmaceuticals Inc (REGN)

Leonard S Schleifer "Len"President/CEO/Co-FounderGeorge D YancopoulosPres:Laboratories
Joseph J Larosa "Joe"Senior VP/Secy/General CounselDaniel P Van PlewSenior VP/Gen Mgr:Industrial Ops
Robert E Landry Jr "Bob"Senior VP:Finance/CFOMurray A GoldbergSenior VP:Administration
Robert J TerifaySenior VP:CommercialPeter PowchikSenior VP:Clinical Development
Neil StahlSenior VP:Research & DevDouglas S McCorkleVP/Asst Treasurer/Controller
Michael AbermanVP:Strategy & Investor Rels

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil